Autopsy report · NCT06112652

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique

“insufficient funds”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Suspended: paused, and may or may not restart.
• 100 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Changping Laboratory

Sponsor type

University, hospital or other

Conditions

Moderate Depression; Major Depressive Disorder; Severe Depression

Interventions

4 session rTMS; 6 session rTMS; 8 session rTMS; 10 session rTMS; sham rTMS

Participants

100 (planned, not actual)

Sites

1

Countries

China

Trials that died the same way

• Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease
  “Insufficient funding” (82% match in meaning)
• Cardiopulmonary Rehabilitation in Post-acute COVID-19 Syndrome
  “Unable to get funds” (80% match in meaning)
• Effectiveness of Podiatry Care on Onychomycosis (EPOCAON)
  “No funds” (77% match in meaning)
• Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
  “Insufficient funding/staff” (77% match in meaning)
• Selenium Supplementation of Patients With Cirrhosis
  “Insufficient funds to complete study.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.